Foghorn Therapeutics (FHTX) Short-term Investments (2019 - 2026)

Foghorn Therapeutics (FHTX) recorded quarterly Short-term Investments of $1.2 million in Q1 2026, little changed quarter-over-quarter from $1.2 million in Q4 2025.

Foghorn Therapeutics (FHTX) Short-term Investments (2019 - 2026) Analysis & Trends

Foghorn Therapeutics' Short-term Investments history runs 5 years deep, the most recent figure standing at $1.2 million for Q1 2026.

  • In Q1 2026, Short-term Investments changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
  • Short-term Investments was $1.2 million for Q1 2026 at Foghorn Therapeutics, roughly flat from $1.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.2 million in Q2 2025 to a low of $25000.0 in Q3 2022.
  • Historically, Short-term Investments has averaged $1.0 million across 3 years, with a median of $1.2 million in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Foghorn Therapeutics 282.33 Mn 193.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.25 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
Sep 30, 2022 25,000.00
Sep 30, 2020 541,000.00
Dec 31, 2019 541,000.00